Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
0.195
-0.006 (-2.74%)
At close: Dec 20, 2024, 4:00 PM
0.202
+0.007 (3.54%)
After-hours: Dec 20, 2024, 7:52 PM EST
Bionano Genomics Stock Forecast
BNGO's stock price has decreased by -87.96% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Bionano Genomics stock has a target of 1.00, which predicts an increase of 412.82% from the current stock price of 0.20.
Analyst Consensus: Hold
* Price targets were last updated on Aug 28, 2024.
Analyst Ratings
The average analyst rating for BNGO stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 10, 2024 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +412.82% | Aug 28, 2024 |
| BTIG | BTIG | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +925.64% | May 16, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +2,976.92% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
30.92M
from 36.12M
Decreased by -14.39%
Revenue Next Year
31.77M
from 30.92M
Increased by 2.74%
EPS This Year
-1.39
from -6.81
EPS Next Year
-0.31
from -1.39
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 35.0M | 37.7M | 48.7M | |||
| Avg | 30.9M | 31.8M | 44.6M | |||
| Low | 28.0M | 27.0M | 40.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.1% | 22.0% | 53.4% | |||
| Avg | -14.4% | 2.7% | 40.4% | |||
| Low | -22.4% | -12.8% | 26.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.40 | -0.21 | -0.15 | |||
| Avg | -1.39 | -0.31 | -0.23 | |||
| Low | -1.39 | -0.47 | -0.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.